CNTA
Centessa Pharmaceuticals plc · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +2.4% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q1 2026 | 55 | +3 | 43.68M | $1.73B | +11 | −8 |
| Q4 2025 | 52 | -1 | 46.49M | $1.16B | n/a | −1 |
| Q3 2025 | 17 | 0 | 26.76M | $648.81M | +1 | −1 |
| Q2 2025 | 14 | +1 | 24.28M | $319.09M | +2 | −1 |
| Q1 2025 | 11 | 0 | 16.47M | $236.89M | n/a | n/a |
| Q4 2024 | 11 | -1 | 15.51M | $259.80M | n/a | −1 |
| Q3 2024 | 11 | +2 | 13.11M | $209.59M | +2 | n/a |
| Q2 2024 | 9 | n/a | 8.99M | $81.17M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 10.04M | +19.4% | $243.35M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 6.28M | +64.1% | $152.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | T. Rowe Price ✦ | 4.80M | -18.7% | $116.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 1.12M | n/a | $27.27M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 5 | Point72 Asset Management ✦ | 1.07M | -58.6% | $26.01M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 6 | Millennium Management ✦ | 902.27K | -45.6% | $21.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 7 | Capital World Investors ✦ | 684.80K | +64.3% | $16.61M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | JPMorgan Chase ✦ | 483.79K | n/a | $11.73M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 9 | BlackRock ✦ (passief) | 408.39K | +7.2% | $9.90M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 10 | Goldman Sachs Group ✦ | 247.56K | n/a | $6.00M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 164.60K | -57.2% | $3.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 137.20K | Nieuw | $3.33M | 0.0% | New | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 113.59K | -66.9% | $2.75M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Geode Capital Management ✦ (passief) | 95.03K | +8.7% | $2.30M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Wellington Management ✦ | 82.67K | -44.7% | $2.00M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 16 | D. E. Shaw & Co. ✦ | 64.39K | +308.5% | $1.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 57.44K | -20.4% | $1.39M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Citadel Advisors | $3.33M | 0.0% |
Verlaten
| State Street Global Advisors | $603,284 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 159 houders, 148.16M aandelen, $5.86B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.